POLR3B and amyotrophic lateral sclerosis: In this manuscript, we show that riluzole, an FDA-approved drug for the treatment of ALS, partially corrects Pol III assembly defects induced by the leukodystrophy-causative amino acid substitution R103H in POLR3B.